We are live on ! Find out more
EBSAM

Eubel Brady & Suttman Asset Management Portfolio holdings

AUM $845M
1-Year Est. Return 12.93%
This Fund
S&P 500
This Quarter Est. Return
-21.24%
1 Year Est. Return
+12.93%
3 Year Est. Return
+37.61%
5 Year Est. Return
+54.42%
10 Year Est. Return
+219.52%
AUM
$334M
AUM Growth
-$39.9M
Cap. Flow
+$62.2M
Cap. Flow %
18.59%
Top 10 Hldgs %
44%
Holding
84
New
9
Increased
39
Reduced
18
Closed
11

Top Buys

Rank Stock Value
1
WBD icon
Warner Bros
WBD
+$10.6M
2
COR icon
Cencora
COR
+$10.4M
3
STLD icon
Steel Dynamics
STLD
+$9.35M
4
LH icon
Labcorp
LH
+$9.22M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$6M

Sector Composition

Rank Sector Weight
1 Healthcare 28.58%
2 Financials 25.38%
3 Technology 12.26%
4 Industrials 10.6%
5 Communication Services 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLF icon
76
State Street Financial Select Sector SPDR ETF
XLF
$59B
-11,028
Closed -$339K
GBT
77
DELISTED
Global Blood Therapeutics, Inc.
GBT
-31,796
Closed -$32K
PRSP
78
DELISTED
Perspecta Inc. Common Stock
PRSP
-10,102
Closed -$267K
AGN
79
DELISTED
Allergan plc
AGN
-78,174
Closed -$14.9M

Similar funds

Eubel Brady & Suttman Asset Management's Q1 2020 Portfolio in Review

As of Q1 2020, Eubel Brady & Suttman Asset Management held 84 positions worth $334M, down 11% from $374M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Eubel Brady & Suttman Asset Management deployed $62.2M of net new capital in Q1 2020, opening 9 new positions and adding to 39 existing holdings. Its largest new stake was Cencora: 118,499 shares worth $10.5M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 26% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Procter & Gamble, an estimated $4.53M trimmed.

  • Eubel Brady & Suttman Asset Management's largest Q1 2020 buy was Cencora: 118,499 shares worth $10.5M.
  • Eubel Brady & Suttman Asset Management added most to Warner Bros in Q1 2020, an estimated $10.6M increase.
  • Eubel Brady & Suttman Asset Management's biggest Q1 2020 reduction was Procter & Gamble, cutting an estimated $4.53M.
  • Eubel Brady & Suttman Asset Management fully exited Allergan plc in Q1 2020, selling an estimated $14.9M.
  • Eubel Brady & Suttman Asset Management's ten largest holdings make up 44% of its $334M portfolio in Q1 2020.
  • Eubel Brady & Suttman Asset Management opened 9 new positions and closed 11 in Q1 2020.
  • Eubel Brady & Suttman Asset Management's portfolio value fell 11% quarter-over-quarter to $334M.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q1 2020, filed 13 May 2020.